{"nct_id":"NCT05274100","title":"Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2020-09-01","start_date_type":"ACTUAL","primary_completion_date":"2021-07-06","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}